A clinical research associate finishes a two-day on-site monitoring visit at an enrolling oncology site and faces the part of the job that no one celebrates: the Monitoring Visit Report. She has a notebook of observations, a query log exported from the electronic data capture system, drug-accountability counts, and the previous MVR that defined the open action items she came to close. The report has to reconstruct what she verified, what she found, what remains open, and what the site must do, in a form that the sponsor's oversight function and an inspector can both rely on years later. An enterprise large language model can turn her visit notes, the query log, and the prior MVR into a structured draft in minutes, which matters when she has four sites behind on reports and the next visit is Thursday. It can also smooth a serious finding into a routine sentence, carry a number from the previous visit that is no longer true, and report a key performance indicator the underlying data does not support. The MVR is a regulatory record under ICH E6(R3), and this lesson is about drafting it with AI without letting the model quietly change what happened at the site.

Why the MVR Is a Regulatory Record, Not a Trip Summary

The Monitoring Visit Report is the documented evidence that the sponsor exercised oversight of a clinical trial site, and that oversight obligation now sits explicitly in ICH E6(R3), the revised Good Clinical Practice guideline whose Section 3.11 addresses monitoring. The R3 revision, with its UK MHRA legal effective date of 28 April 2026, reframes monitoring around a risk-based approach: monitoring activities and their documentation should reflect the risks to participant safety and data reliability, rather than applying uniform 100 percent verification everywhere. The MVR is where that risk-based monitoring becomes a record, capturing what was monitored, why, what was found, and what follows. An inspector reading the trial master file reads the MVRs as the proof that the sponsor was watching, and a gap or contradiction in that record is a finding in itself.

This regulatory weight is exactly what the model does not understand it is handling. To the model, the MVR is a document type with a familiar structure, and it can reproduce that structure fluently from the inputs it is given. It does not know that an MVR is read by a sponsor oversight committee deciding whether a site needs escalation, by a quality function tracking systemic issues across sites, and potentially by an FDA or EMA inspector reconstructing whether participant safety was protected. The CRA who signs the MVR is attesting that it accurately reflects the visit, and that attestation is the load-bearing element, exactly as a medical writer attests to a Clinical Overview and an MI specialist attests to an SRD. The model drafts the reconstruction; the named CRA guarantees it is true to the visit.

The risk-based framing of E6(R3) raises the stakes of accuracy in a specific way. Because monitoring is now targeted at the highest-risk data and processes, the MVR's account of what was checked and what was found feeds directly into the sponsor's risk picture for the site and the study. A report that overstates verification, understates a finding, or misreports a metric does not just contain an error; it corrupts the risk-based oversight system that depends on accurate monitoring records to decide where to look next. The accuracy of the MVR is therefore not a clerical virtue but a patient-safety and data-integrity control, and that is the frame the human brings and the model cannot.

The Three Inputs and What Each Contributes

The AI-assisted MVR draws on three named sources, and understanding what each contributes, and how each can mislead the model, is the foundation of drafting it safely. The first is the CRA's visit notes: the contemporaneous record of what she observed, verified, and discussed on site. These are the ground truth of the visit, and they are also unstructured, incomplete, and shorthand, which means the model summarizing them can fill gaps with plausible content the notes do not actually contain. A note that reads "ICF dates checked, 2 issues" can become, in a fluent draft, a confident paragraph about informed-consent compliance that asserts more than the CRA wrote, and the human must keep the draft anchored to what the notes actually say.

The second input is the eCRF query log, the export from the electronic data capture system showing the data queries raised, answered, and outstanding for the site. This is structured data, and it is the source for several of the MVR's metrics, but it is also exactly the kind of input from which a model will compute or assert a number that looks derived and may be wrong. Asked to summarize the query log, the model can state a query count, an aging figure, or a resolution rate that does not match the actual export, because producing a plausible metric is what it does. The query log metrics must be computed from the log, not generated by the model, and reconciled against the export the CRA actually holds.

The third input is the previous MVR, which defines the action items and open issues the current visit was meant to address, and this is the input with the most dangerous failure mode. The model, given the prior MVR, will readily carry forward its content, including findings, counts, and statuses that the current visit may have changed or resolved. A drug-accountability figure, an open-query count, or a deviation status from the last visit can appear in the new draft as though it were current, because the model treats the prior report as context to continue rather than a baseline to update. The human must verify that every carried-forward item reflects the current state, and that resolved items are marked resolved and new findings are captured, because a stale number presented as current is one of the most common and least visible MVR errors.

The Named KPIs and Why They Must Be Computed, Not Generated

An MVR is partly a narrative and partly a set of metrics, and the metrics are where AI assistance is both most tempting and most dangerous. Six named key performance indicators recur across monitoring reports, and each is a number that must be computed from a source rather than produced by the model. The source data verification percentage records how much of the critical data was verified against source, a figure that under E6(R3) should reflect the risk-based plan rather than a blanket target. The query cycle, the time from query raised to query resolved, measures data-cleaning responsiveness at the site. The screen-failure rate, the proportion of screened participants who failed eligibility, is a signal of both protocol fit and site behavior.

The remaining three are equally consequential. The drug-accountability variance, the discrepancy between expected and actual investigational product counts, is a safety and integrity signal, because an unexplained variance can indicate a dosing error, a dispensing problem, or worse. The protocol-deviation rate, the frequency of deviations at the site, feeds the quality picture and can trigger escalation. The monitoring-visit cycle time, the interval between visits relative to the plan, measures whether the site is being monitored at the cadence its risk profile requires. Each of these is a precise figure with a precise source, and each is exactly the kind of value a model will generate plausibly if the source is not loaded and the computation not enforced.

The discipline mirrors the one from the submission world: a metric stated in the MVR is a claim about the data, and a claim must trace to its source. The SDV percentage traces to the monitoring records of what was verified; the query metrics trace to the eCRF query log; the drug-accountability variance traces to the accountability counts; the deviation rate traces to the deviation log; the cycle times trace to the visit schedule. The CRA reconciles every KPI against its source and rejects any figure the model produced that she cannot trace, treating a plausible-looking metric with no traceable computation as wrong until proven right. A KPI dashboard that looks clean but contains a generated number is worse than no dashboard, because the sponsor's oversight acts on it.

Where the Model Smooths a Finding Into Noise

The most insidious MVR failure is not a wrong number; it is a softened finding. A monitoring visit exists to surface problems, and the serious ones, an informed-consent deviation, a missed safety assessment, an eligibility violation, a drug-accountability discrepancy, are precisely the findings that matter most and that a fluent summarizer tends to round off. The model's instinct, learned from a corpus of measured professional prose, is to render a sharp observation in calm, even language, so a CRA's note flagging a potential consent problem can become a draft sentence that mentions consent documentation was reviewed, with the alarm drained out of it. The finding is technically present and practically invisible.

This matters because the MVR's escalation function depends on findings being legible as findings. The sponsor's oversight reads the MVR to decide whether a site needs corrective action, additional monitoring, or escalation, and that decision turns on the report conveying the actual severity of what the CRA found. A report that records a serious finding in routine language has not just understated a problem; it has defeated the purpose of the visit, because the oversight function will not act on a problem it cannot see. The human reads the draft against her own sense of what mattered at the visit, confirming that serious findings are stated with their actual weight and that the report would prompt the response the situation warrants.

The inverse error exists too and is also the model's tendency: inflating a routine observation into a finding through over-formal language, which floods the oversight function with noise and dilutes the signal of the genuine issues. Calibrated severity, stating serious things seriously and minor things as minor, is a human judgment the model does not reliably reproduce, because it writes most things in the same even register regardless of weight. The CRA owns the severity calibration of the MVR, ensuring the report's emphasis matches the visit's reality, because an MVR that misweights its findings misdirects the oversight that reads it.

Maintaining ICH E6(R3) Section 3.11 Alignment in the Draft

Beyond accuracy, the MVR must align to the monitoring expectations of ICH E6(R3) Section 3.11, and that alignment is structural and substantive in ways the model approximates but does not guarantee. Structurally, the report should reflect the risk-based monitoring approach: it should document monitoring of the critical data and processes the monitoring plan prioritized, rather than implying uniform verification of everything. A model trained on older monitoring reports, many of which predate the R3 framing and assume 100 percent source data verification, can draft an MVR that describes a blanket-verification model the current plan does not use, putting the report out of step with the study's own risk-based monitoring plan.

Substantively, E6(R3) ties monitoring to participant safety and data reliability, which means the MVR should connect what was monitored to those risks, documenting not just that data was checked but that the checks addressed the things most likely to harm participants or corrupt the data. The model can produce a structurally complete MVR that lists activities without making this connection, because the connection requires understanding the study's specific risks, which live in the monitoring plan and the CRA's judgment, not in the document's generic shape. The human ensures the MVR reflects the actual risk-based plan, references the monitoring activities the plan called for, and documents the findings in terms of their risk significance, so the report is aligned to R3 rather than merely formatted like a monitoring report.

The Audit Trail and the CRA's Attestation

An MVR is a controlled document that enters the trial master file and the sponsor's clinical trial management system, and an AI-assisted MVR has to carry the same defensibility as any other. Because the draft was AI-assisted and because model output varies, the record should capture how the MVR was produced: the inputs loaded, the visit notes, the query log, the prior MVR, the model and version, and the human verification steps that reconciled the KPIs, updated the carried-forward items, and calibrated the findings. This is the ALCOA+ discipline applied to a monitoring record, ensuring the MVR is attributable, accurate, and complete, with a traceable account of the human work that made the AI draft trustworthy.

The attestation is the point on which everything rests. When the CRA signs the MVR, she is certifying that it accurately reflects the visit, the findings, and the metrics, and that certification is meaningful only if she did the verification the model cannot do. A CRA who signs an AI-drafted MVR she has not reconciled against the query log, the accountability counts, and the prior report has attested to content she did not verify, which is the failure mode the entire discipline exists to prevent. The sponsor's oversight, the quality function, and the inspector all rely on the CRA's signature meaning what it claims, and the AI use log is the evidence that the signature is backed by verification rather than by trust in the tool.

What This Means for the CRA on Monday

The MVR is a genuinely good candidate for AI assistance because it is structured, repetitive, and built from defined inputs, and a CRA buried under a monitoring backlog reclaims real hours by letting the model assemble the first draft from her notes, the query log, and the prior report. But the hours are reclaimed only inside a verification discipline that follows from what the MVR is: a regulatory record under ICH E6(R3) on which patient-safety and data-integrity oversight depends. The model can reconstruct the visit's shape; it cannot guarantee that the reconstruction is true, and the gap between a plausible MVR and an accurate one is the CRA's to close.

So she loads the real inputs before drafting, because the model reasons only over what it is given. She computes every KPI from its source and reconciles it, rejecting any metric she cannot trace. She checks every carried-forward item from the prior MVR against the current state, marking resolved what is resolved and capturing what is new, so no stale number rides forward as current. She reads the draft for severity, confirming serious findings are stated seriously and routine ones are not inflated, so the report drives the oversight the situation warrants. She confirms the MVR reflects the risk-based monitoring plan rather than an outdated blanket-verification model. She captures the run for the trial master file, and then she signs, attesting to a record she has verified. The model drafted the MVR in minutes; the named CRA made it true to the visit, and her signature means what it claims.

Key Takeaways

• The MVR is a regulatory record under ICH E6(R3) Section 3.11, and its accuracy is a patient-safety and data-integrity control. Because R3 monitoring is risk-based, the MVR's account of what was checked and found feeds the sponsor's risk picture, so an overstated verification or understated finding corrupts the oversight system. The named CRA attests that the report is true to the visit, and that attestation is the load-bearing element.
• The three inputs each mislead the model differently, and the prior MVR is the most dangerous. Visit notes are unstructured and the model fills gaps with content the notes lack; the query log is structured and the model asserts metrics that do not match the export; the previous MVR is carried forward so that stale findings, counts, and statuses appear as current unless every item is checked against the present state.
• The six named KPIs must be computed from a source, never generated. SDV percentage, query cycle, screen-failure rate, drug-accountability variance, protocol-deviation rate, and monitoring-visit cycle time each trace to a specific source, and a model will produce a plausible figure if the source is not loaded and the computation not enforced. A clean-looking dashboard with a generated number is worse than none, because oversight acts on it.
• The model smooths serious findings into routine sentences and inflates routine ones into findings. A consent or safety problem rendered in calm, even language is technically present and practically invisible, defeating the MVR's escalation function, while over-formalized trivia floods oversight with noise. The CRA owns the severity calibration so the report's emphasis matches the visit's reality.
• E6(R3) alignment is substantive, not just structural, and the attestation rests on verification. The MVR must reflect the study's risk-based monitoring plan rather than an outdated 100 percent verification model, and connect monitoring to participant-safety and data-reliability risks. The CRA captures the run for the trial master file and signs only what she has reconciled against the query log, the accountability counts, and the prior report.